APA (7th ed.) Citation

HY, L., TK, C., K, C. S., BMY, C., KH, Y., HF, T., & YH, C. (2026). GLP-1 Receptor Agonists and Risk of Optic Nerve or Vision-Threatening Events in Patients With Type 2 Diabetes or Cardiometabolic Diseases: A Meta-analysis of Randomized Controlled Trials. Diabetes care, 49(3), 526. https://doi.org/10.2337/dc25-1929

Chicago Style (17th ed.) Citation

HY, Li, Chan TK, Co Shih K, Cheung BMY, Yiu KH, Tse HF, and Chan YH. "GLP-1 Receptor Agonists and Risk of Optic Nerve or Vision-Threatening Events in Patients With Type 2 Diabetes or Cardiometabolic Diseases: A Meta-analysis of Randomized Controlled Trials." Diabetes Care 49, no. 3 (2026): 526. https://doi.org/10.2337/dc25-1929.

MLA (9th ed.) Citation

HY, Li, et al. "GLP-1 Receptor Agonists and Risk of Optic Nerve or Vision-Threatening Events in Patients With Type 2 Diabetes or Cardiometabolic Diseases: A Meta-analysis of Randomized Controlled Trials." Diabetes Care, vol. 49, no. 3, 2026, p. 526, https://doi.org/10.2337/dc25-1929.